Stephan Grupp, MD, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, discusses whether CAR-T therapy can be a frontline standard of care and first-line therapy in acute lymphoblastic leukemia (ALL). This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

свернуть